APA način citiranja

Sanford, D., Kantarjian, H., Skinner, J., Jabbour, E., & Cortes, J. (2015). Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor. Haematologica.

Čikaški stil citiranja

Sanford, David, Hagop Kantarjian, Jeffrey Skinner, Elias Jabbour, i Jorge Cortes. "Phase II Trial of Ponatinib in Patients With Chronic Myeloid Leukemia Resistant to One Previous Tyrosine Kinase Inhibitor." Haematologica 2015.

MLA način citiranja

Sanford, David, et al. "Phase II Trial of Ponatinib in Patients With Chronic Myeloid Leukemia Resistant to One Previous Tyrosine Kinase Inhibitor." Haematologica 2015.